Publications by authors named "Catherine Nakao"

Article Synopsis
  • The study investigates the persistence of germinal centre B cells for over 6 months following HIV Env protein immunization in rhesus monkeys, showing a significant increase in B cells at week 10 compared to conventional methods.
  • Continuous somatic hypermutation of the B cells during the 29-week period indicates ongoing selection pressure, leading to a substantial boost in HIV-neutralizing antibodies after a single booster.
  • Findings suggest that a longer priming strategy can enhance immune memory, allowing B cells to better recognize challenging antigens, potentially improving vaccine efficacy for difficult targets.
View Article and Find Full Text PDF

Elicitation of HIV broadly neutralizing antibodies (bnAbs) is challenging because unmutated bnAb precursors are rare and seldom bind HIV envelope glycoprotein (Env) trimers. One strategy to initiate bnAb responses is to use germline-targeting (GT) immunogens with high affinity to bnAb-class precursor B cells and then shepherd affinity maturation with booster immunogens that successively look more like native Env. In a mouse model where the frequency of VRC01-precursor (VRC01) B cells mimics that of humans, we show that following a GT HIV Env trimer protein prime, VRC01-class B cells in the germinal center (GC) acquire high-affinity VRC01-class B cell somatic hypermutations (SHMs).

View Article and Find Full Text PDF
Article Synopsis
  • - There's a global need for better, low-cost vaccines against SARS-CoV-2, and aluminum hydroxide (alum) is the most common vaccine adjuvant but gives only modest immune responses.
  • - Researchers found that modifying the receptor binding domain (RBD) of the virus with phosphoserine peptides helps it bind to alum and stay in the body longer, which leads to stronger immune responses in mice.
  • - Combining this modified RBD with additional phosphate-containing adjuvants significantly boosts immunogenicity, producing strong neutralizing antibodies against SARS-CoV-2 variants in both mice and rhesus macaques.
View Article and Find Full Text PDF

Understanding immune memory to SARS-CoV-2 is critical for improving diagnostics and vaccines, and for assessing the likely future course of the COVID-19 pandemic. We analyzed multiple compartments of circulating immune memory to SARS-CoV-2 in 254 samples from 188 COVID-19 cases, including 43 samples at ≥ 6 months post-infection. IgG to the Spike protein was relatively stable over 6+ months.

View Article and Find Full Text PDF

Understanding immune memory to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for improving diagnostics and vaccines and for assessing the likely future course of the COVID-19 pandemic. We analyzed multiple compartments of circulating immune memory to SARS-CoV-2 in 254 samples from 188 COVID-19 cases, including 43 samples at ≥6 months after infection. Immunoglobulin G (IgG) to the spike protein was relatively stable over 6+ months.

View Article and Find Full Text PDF

Immunodominance to nonneutralizing epitopes is a roadblock in designing vaccines against several diseases of high interest. One hypothetical possibility is that limited CD4 T cell help to B cells in a normal germinal center (GC) response results in selective recruitment of abundant, immunodominant B cells. This is a central issue in HIV envelope glycoprotein (Env) vaccine designs, because precursors to broadly neutralizing epitopes are rare.

View Article and Find Full Text PDF

Conventional immunization strategies will likely be insufficient for the development of a broadly neutralizing antibody (bnAb) vaccine for HIV or other difficult pathogens because of the immunological hurdles posed, including B cell immunodominance and germinal center (GC) quantity and quality. We found that two independent methods of slow delivery immunization of rhesus monkeys (RMs) resulted in more robust T follicular helper (T) cell responses and GC B cells with improved Env-binding, tracked by longitudinal fine needle aspirates. Improved GCs correlated with the development of >20-fold higher titers of autologous nAbs.

View Article and Find Full Text PDF

Objective- Three distinct human monocyte subsets have been identified based on the surface marker expression of CD14 and CD16. We hypothesized that monocytes were likely more heterogeneous in composition. Approach and Results- We used the high dimensionality of mass cytometry together with the FlowSOM clustering algorithm to accurately identify and define monocyte subsets in blood of healthy human subjects and those with coronary artery disease (CAD).

View Article and Find Full Text PDF

Objective: Human monocyte subsets are defined as classical (CD14CD16), intermediate (CD14CD16), and nonclassical (CD14CD16). Alterations in monocyte subset frequencies are associated with clinical outcomes, including cardiovascular disease, in which circulating intermediate monocytes independently predict cardiovascular events. However, delineating mechanisms of monocyte function is hampered by inconsistent results among studies.

View Article and Find Full Text PDF